David Mauro

3.0k total citations · 1 hit paper
76 papers, 2.1k citations indexed

About

David Mauro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, David Mauro has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in David Mauro's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Toxic Organic Pollutants Impact (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). David Mauro is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Toxic Organic Pollutants Impact (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). David Mauro collaborates with scholars based in United States, Spain and Germany. David Mauro's co-authors include Christine H. Chung, Diane R. Gold, Beloo Mirakhur, Jacob D. Hosen, Tina Hatley, Thomas A.E. Platts‐Mills, Shama M. Satinover, Barbara A. Murphy, Quynh‐Thu Le and Daniel J. Hicklin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Mauro

68 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

2008 1.1k citations Christine H. Chung, Beloo Mirakhur et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Mauro United States	18	609	554	486	429	335	76	2.1k
Atsushi Kuramoto Japan	29	1.6k 2.6×	1.4k 2.5×	610 1.3×	1.1k 2.5×	260 0.8×	157	4.7k
Uğur Çoşkun Türkiye	26	535 0.9×	862 1.6×	198 0.4×	255 0.6×	39 0.1×	174	2.3k
KC Anderson United States	32	1.3k 2.1×	1.5k 2.7×	260 0.5×	817 1.9×	213 0.6×	82	3.8k
Florian Fritzsche Germany	28	944 1.6×	651 1.2×	163 0.3×	142 0.3×	99 0.3×	51	2.0k
Alberto Costa Italy	27	1.0k 1.7×	1.1k 1.9×	477 1.0×	269 0.6×	40 0.1×	68	2.6k
Luc de Chaisemartin France	21	346 0.6×	1.2k 2.2×	79 0.2×	1.6k 3.8×	174 0.5×	51	2.4k
Mats G. Karlsson Sweden	32	854 1.4×	751 1.4×	102 0.2×	177 0.4×	88 0.3×	97	2.7k
Ming Yin United States	30	1.3k 2.1×	1.1k 1.9×	250 0.5×	189 0.4×	242 0.7×	80	3.1k
Heidi Chen United States	34	1.3k 2.1×	1.3k 2.3×	328 0.7×	300 0.7×	70 0.2×	108	3.5k
Hubert Zirngibl Germany	31	491 0.8×	1.1k 2.0×	131 0.3×	283 0.7×	307 0.9×	133	3.6k

Countries citing papers authored by David Mauro

Since Specialization

Citations

This map shows the geographic impact of David Mauro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mauro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mauro more than expected).

Fields of papers citing papers by David Mauro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Mauro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mauro. The network helps show where David Mauro may publish in the future.

Co-authorship network of co-authors of David Mauro

This figure shows the co-authorship network connecting the top 25 collaborators of David Mauro. A scholar is included among the top collaborators of David Mauro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Mauro. David Mauro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moon, Andrew M., Sasha Deutsch‐Link, Louise M. Henderson, et al.. (2025). Rural-Urban Disparities in Hepatocellular Carcinoma Deaths Are Driven by Hepatitis C-Related Hepatocellular Carcinoma. The American Journal of Gastroenterology. 121(2). 353–361.

Yu, Shawn, Menggang Yu, David Mauro, et al.. (2024). A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma. The Oncologist. 29(3). 270–e413. 20 indexed citations

Shah, Neil, et al.. (2022). Anastomosing hemangioma of the liver: An unusual variant in abdominal MRI imaging. SHILAP Revista de lepidopterología. 17(12). 4889–4892. 6 indexed citations

Yacoub, Joseph H., Christine Hsu, Thomas Fishbein, et al.. (2021). Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation—part one: curative intention. Abdominal Radiology. 46(8). 3528–3539. 10 indexed citations

Commander, Clayton W. & David Mauro. (2021). Current Approach to Planning Angiography and MAA Administration. Seminars in Interventional Radiology. 38(4). 397–404. 2 indexed citations

Mauro, David, et al.. (2020). Creating an Open-Access Educational Radiology Website for Medical Students: A Guide for Radiology Educators. Academic Radiology. 28(11). 1631–1636. 12 indexed citations

Aurisicchio, Luigi, Arthur Fridman, David Mauro, et al.. (2020). Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study. Journal of Translational Medicine. 18(1). 39–39. 19 indexed citations

Moon, Andrew M., Paul H. Hayashi, David A. Gerber, et al.. (2020). Stereotactic Body Radiation Therapy for Recurrent, Isolated Hepatocellular Carcinoma Lymph Node Metastasis With or Without Prior Liver Transplantation. Cureus. 12(8). e9988–e9988. 6 indexed citations

Baselga, José, Serafín Morales, Ahmad Awada, et al.. (2017). A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer. Breast Cancer Research and Treatment. 163(3). 535–544. 16 indexed citations

10.

Shah, Puja, David Mauro, Charles M. Friel, & Traci L. Hedrick. (2016). A Retrospective, Observational Study of the Adequacy of Elective Loop Stoma Diversion.. PubMed. 62(5). 30–40. 1 indexed citations

11.

Amin, Manik, Susan Minton, Patricia LoRusso, et al.. (2015). A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors. Investigational New Drugs. 34(1). 84–95. 35 indexed citations

12.

Morán, Teresa, Enriqueta Felip, Vicki L. Keedy, et al.. (2014). Activity of dalotuzumab, a selective anti-IGF1R antibody, in combination with erlotinib in unselected patients with Non-small-cell lung cancer: a phase I/II randomized trial. Experimental Hematology and Oncology. 3(1). 26–26. 27 indexed citations

13.

Rosenberger, Laura H., et al.. (2014). Delayed Endoluminal Vacuum Therapy for Rectal Anastomotic Leaks after Rectal Resection in a Swine Model: A New Treatment Option. Clinical and Translational Science. 7(2). 121–126. 8 indexed citations

14.

Rosenberger, Laura H., Timothy E. Newhook, David Mauro, Sara A. Hennessy, & Robert G. Sawyer. (2012). Jejunal tube extensions via percutaneous endoscopic gastrostomy and delayed small-bowel perforations: a case series. Gastrointestinal Endoscopy. 75(3). 683–687. 4 indexed citations

15.

Lang, Kathleen, Marc Sussman, Jun Su, et al.. (2009). Incidence and Costs of Treatment-Related Complications Among Patients With Advanced Squamous Cell Carcinoma of the Head and Neck. Archives of Otolaryngology - Head and Neck Surgery. 135(6). 582–588. 37 indexed citations

16.

Robinson, Douglas, David Mauro, Christine Chung, et al.. (2008). Utility of cetuximab-cross reactive IgE as a predictive biomarker for cetuximab associated severe infusion reactions. Clinical Cancer Research. 14. 1 indexed citations

17.

Chung, Christine H., Beloo Mirakhur, Emily Chan, et al.. (2008). Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose. New England Journal of Medicine. 358(11). 1109–1117. 1075 indexed citations breakdown →

18.

Garrett, Christopher, Edwin Clark, Mark Basik, et al.. (2007). Expression of epiregulin and amphiregulin and K-RAS mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab (Erbitux ®). Cancer Research. 67. 5670–5670. 3 indexed citations

19.

Mauro, David, et al.. (2005). Applications of forensic chemistry to environmental work. Journal of Industrial Microbiology & Biotechnology. 32(11-12). 665–668. 10 indexed citations

20.

Weyand, Eric H., et al.. (1991). Urinary excretion and DNA binding of coal tar components in B6C3F1 mice following ingestion. Chemical Research in Toxicology. 4(4). 466–473. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact